Praxis Precision Medicines Inc.

PRAX | NASDAQ

Price Alert Chart Builder DCF Calculator

$298.87

-$0.08 (-0.03%)

At close: Sep 21, 2026, 4:00 PM ET

$299.94

+$1.07 (+0.36%)

Pre-market: Sep 22, 2026, 4:56 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $8.33B

Enterprise Value $7.57B

Beta 2.78

Average Volume 460.35K

Shares Outstanding (Diluted) 29.13M

Shares Change YoY 35.65%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US74006W2070

Price Performance

Price Change 1M -20.5%

Price Change 3M -2.1%

Price Change 6M -4.2%

Price Change YTD 4.3%

Price Change 1Y 518.4%

Price Change 3Y 1283.7%

Price Change 5Y -0.3%

1M CAGR (ann.) -19.2%

1Y CAGR (ann.) 579.0%

5Y CAGR (ann.) -1.0%

All-Time CAGR -5.5%

Valuation

PE Ratio -23.11

Forward PE N/A

PEG Ratio 4.10

Forward PEG 0.85

PS Ratio N/A

Forward PS 23.80

PB Ratio 6.21

P/FCF Ratio -27.23

P/Adj. FCF Ratio -25.66

P/OCF Ratio -28.49

EV/Sales N/A

EV/EBIT -22.34

EV/EBITDA -22.34

EV/FCF -24.75

Earnings Yield -4.3%

FCF Yield -3.7%

Adj. FCF Yield -3.9%

Financial Health

Net Cash $757.46M

Total Debt $1.09M

Cash & Short-Term Investments $758.55M

Total Assets $1.39B

Current Ratio 15.73

Quick Ratio 15.73

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -281.22

Interest Coverage 0.00

Altman Z-Score 100.43

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.1%

Returns

Return on Assets -24.4%

Return on Equity -34.1%

Return on Invested Capital -28.2%

Return on Capital Employed -28.2%

Return on Tangible Assets -24.4%

Historical Growth (CAGR)

Revenue CAGR 3Y -27.9%

Revenue CAGR 5Y 28.6%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -11.2%

EPS CAGR 5Y 51.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -53.6%

FCF CAGR 5Y -16.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 18

EPS Growth Next 3Y 105.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$3.65

EPS Growth Est (next Q) 8.6%

Revenue Est (next Q) $130.77K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $603.83

Price Target Upside 102.0%

Cash Flow

Operating Cash Flow $-305.69M

Free Cash Flow $-306M

Adj. Free Cash Flow $-324.75M

FCF Per Share -$10.50

OCF Per Share -$10.49

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-143.34M

Operating Income $-378.17M

EBITDA $-339.01M

Net Income $-339.13M

EPS (Diluted) -$12.93

Revenue / Employee N/A

Profit / Employee $-2.02M

Employees 168